3/20
08:08 am
ARCT
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Low
Report
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
3/11
07:50 am
ARCT
Rating for ARCT
Low
Report
Rating for ARCT
3/8
11:10 am
ARCT
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "outperform" rating re-affirmed by analysts at William Blair.
3/8
11:10 am
ARCT
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "outperform" rating re-affirmed by analysts at William Blair.
3/8
07:48 am
ARCT
Rating for ARCT
Medium
Report
Rating for ARCT
3/8
07:48 am
ARCT
Rating for ARCT
Medium
Report
Rating for ARCT
2/8
11:03 am
ARCT
Rating for ARCT
Low
Report
Rating for ARCT
2/8
11:03 am
ARCT
Rating for ARCT
Low
Report
Rating for ARCT